Search results for "Oct"

showing 10 items of 3052 documents

Strange baryon production in Z hadronic decays

1995

A study of the production of strange octet and decuplet baryons in hadronic decays of the Z recorded by the DELPHI detector at LEP is presented. This includes the first measurement of the ∑± average multiplicity. The total and differential cross sections, the event topology and the baryon-antibaryon correlations are compared with current hadronization models. © 1995 Springer-Verlag.

Particle physicsPhysics and Astronomy (miscellaneous)OctetLUND MONTE-CARLO; JETS; Z(0)LUND MONTE-CARLOElectron–positron annihilationHadronNuclear TheoryElementary particle01 natural sciencesPartícules (Física nuclear)Nuclear physics0103 physical sciences[PHYS.HEXP]Physics [physics]/High Energy Physics - Experiment [hep-ex]Quantum field theoryMultiplicity (chemistry)010306 general physicsNuclear ExperimentEngineering (miscellaneous)hadronic decayDELPHIPhysicsbaryon-anti-baryon correlation010308 nuclear & particles physicsHigh Energy Physics::PhenomenologyZ(0)DELPHI; hadronic decay; baryon-anti-baryon correlationLARGE ELECTRON POSITRON COLLIDERHadronizationBaryonPARTICLE PHYSICS; LARGE ELECTRON POSITRON COLLIDER; DELPHIJETSPARTICLE PHYSICSFísica nuclearHigh Energy Physics::ExperimentParticle Physics - Experiment
researchProduct

Observador agudo de nuestro tiempo

2010

PartitocraciaMúnichComplutenseDoctor honoris causaVidal-Beneyto JoséEspañaDiversidad culturalTransiciónPolíticaSobre José Vidal-Beneyto: Necrológicas y referencias póstumasContubernioMemoria democráticaObservadorIzquierdaEl PaísJOSÉ VIDAL-BENEYTOPepínEuropeísta convencidoGlobalizaciónValenciaEuropaSociologíaCHEE
researchProduct

Paternal shift-working and sleep disorders in children affected by primary nocturnal enuresis

2017

Objectives: Primary monosymptomatic nocturnal enuresis (PMNE) is a common problem in childhood and studies about the sleep habits of affected children are not conclusive. Work-family conflict (WFC) results from the incompatibility between family demands and business/workplace needs. WFC can impact parental quality with many consequences on children health. Aim of study is assessing the prevalence of sleep disturbances in enuretic children, sons of work-shifters. Materials and methods: 80 children (67 males) aged 5-13 years (mean 10,43; SD ± 1,99), were consecutively referred for PMNE. Sleep habits were investigated with Sleep Disturbances Scale for Children (SDSC) and the results were compa…

Paternal shift-working; Primary nocturnal enuresis; SDSC; Medicine (all)Settore M-PSI/04 - Psicologia Dello Sviluppo E Psicologia Dell'EducazioneSDSCPaternal shift-workingMedicine (all)Primary nocturnal enuresiSettore MED/39 - Neuropsichiatria Infantile
researchProduct

Correlation Between Ischemic Retinal Accidents and Radial Peripapillary Capillaries in the Optic Nerve Using Optical Coherence Tomographic Angiograph…

2017

Background: Perfusion of the optic nerve has been widely studied using fluorescein angiography (FAG), which is currently regarded as the criterion standard. However, FAG has adverse effects associated with intravenous contrast administration and is limited in its capacity to characterize and stratify the different vascular layers of the optic nerve and retina. The use of new imaging techniques, such as optical coherence tomographic angiography (Angio-OCT), is therefore important. Aim: A qualitative description is made of the vascular layers of the optic nerve and of how vascular events affect radial peripapillary capillaries (RPC). Two patients with central retinal artery occlusion (CRAO), …

Pathologymedicine.medical_specialtygenetic structuresShort ReportUlls Cirurgia01 natural sciences03 medical and health scienceschemistry.chemical_compound0302 clinical medicinelcsh:OphthalmologyOphthalmologymedicineradial peripapillary capillaries (RPC)posterior ciliary artery0101 mathematicsarteritic anterior ischemic optic neuropathy (AAION)Retinamedicine.diagnostic_testcentral retinal artery occlusion (CRAO)business.industry010102 general mathematicsRetinalFluorescein angiographymedicine.diseaseeye diseasesArteritic anterior ischemic optic neuropathymedicine.anatomical_structurechemistrylcsh:RE1-994Angiography030221 ophthalmology & optometryOptic nerveCentral retinal artery occlusionsense organsbusinessPerfusionAngio-OCTOphthalmology and Eye Diseases
researchProduct

Benign nocturnal alternating hemiplegia of childhood: a new case with unusual findings

2014

Abstract It has been described a neuro developmental disorder labelled “Benign nocturnal alternating hemiplegia of childhood” (BNAHC) characterized by recurrent attacks of nocturnal hemiplegia without progression to neurological or intellectual impairment. We report a female patient who at 11 months revealed a motionless left arm, unusual crying without impairment of consciousness and obvious precipitating factors. The attacks occur during sleep in the early morning with lack of ictal and interictal electroencephalographic abnormalities, progressive neurological deficit, and cognitive impairment. Unlike previous reports of BNAHC our patient come from a family with a history of both migraine…

Pediatricsmedicine.medical_specialtyHemiplegiaNocturnalHemiplegic migraineDiagnosis DifferentialDevelopmental NeuroscienceSettore M-PSI/08 - Psicologia ClinicamedicineHumansIctalFamilyBenign nocturnal alternating hemiplegia of childhood; Alternating hemiplegia of childhood; Hemiplegic migraine; Sleep disordersSettore M-PSI/02 - Psicobiologia E Psicologia FisiologicaCryingIntellectual impairmentAlternating hemiplegia of childhoodSleep disordersGeneral Medicinemedicine.diseaseSettore MED/39 - Neuropsichiatria InfantileDevelopmental disorderMigraineAlternating hemiplegia of childhoodChild PreschoolPediatrics Perinatology and Child HealthHemiplegic migrainePhysical therapyFemaleNeurology (clinical)medicine.symptomPsychologySleepBenign nocturnal alternating hemiplegia of childhood
researchProduct

Visuomotor competencies and primary monosymptomatic nocturnal enuresis in prepubertal aged children

2013

Maria Esposito,1 Beatrice Gallai,2 Lucia Parisi,3 Michele Roccella,3 Rosa Marotta,4 Serena Marianna Lavano,4 Giovanni Mazzotta,5 Giuseppina Patriciello,1 Francesco Precenzano,1 Marco Carotenuto1 1Clinic of Child and Adolescent Neuropsychiatry, Department of Mental Health, Physical and Preventive Medicine, Second University of Naples, Italy; 2Unit of Child and Adolescent Neuropsychiatry, University of Perugia, Italy; 3Child Neuropsychiatry, Department of Psychology, University of Palermo, Italy; 4Department of Psychiatry, "Magna Graecia" University of Catanzaro, Catanzaro, Italy; 5Unit of Child and Adolescent Neuropsychiatry, AUSL Umbria 2, Terni, Italy Background: Primary …

Pediatricsmedicine.medical_specialtyNeuropsychiatric Disease and TreatmentPopulationNeurosciences. Biological psychiatry. Neuropsychiatryprimary monosymptomatic nocturnal enuresis visuomotor integration childhood rehabilitation VMI M-ABCEnuresisvisuomotor integrationmedicineMass indexM-ABCRC346-429educationBiological PsychiatryOriginal Researcheducation.field_of_studyIntelligence quotientbusiness.industrychildhood rehabilitationprimary monosymptomatic nocturnal enuresisVMISettore MED/39 - Neuropsichiatria InfantileMotor coordinationPsychiatry and Mental healthLanguage developmentLearning disabilityPopulation studyNeurology. Diseases of the nervous systemmedicine.symptombusinessRC321-571
researchProduct

Primary nocturnal enuresis as a risk factor for sleep disorders: an observational questionnaire-based multicenter study

2013

Maria Esposito,1 Beatrice Gallai,2 Lucia Parisi,3 Michele Roccella,3 Rosa Marotta,4 Serena Marianna Lavano,4 Giovanni Mazzotta,5 Marco Carotenuto11Center for Childhood Headache, Clinic of Child and Adolescent Neuropsychiatry, Department of Mental Health, Physical and Preventive Medicine, Second University of Naples, Naples, Italy; 2Unit of Child and Adolescent Neuropsychiatry, University of Perugia, Perugia, Italy; 3Child Neuropsychiatry, Department of Psychology, University of Palermo, Palermo, Italy; 4Department of Psychiatry, “Magna Graecia” University of Catanzaro, Catanzaro, Italy; 5Unit of Child and Adolescent Neuropsychiatry, AUSL Umbria 2, Terni, ItalyIntroductio…

Pediatricsmedicine.medical_specialtyNeuropsychiatric Disease and Treatmentprimary nocturnal enuresisPopulationNeurosciences. Biological psychiatry. NeuropsychiatryLogistic regressionSDSCmedicinesleepRisk factorRC346-429educationPathologicalBiological PsychiatryOriginal Researcheducation.field_of_studybusiness.industryprimary nocturnal enuresis SDSC sleepOdds ratioSleep in non-human animalsSettore MED/39 - Neuropsichiatria InfantileConfidence intervalPsychiatry and Mental healthObservational studyNeurology. Diseases of the nervous systembusinessRC321-571Neuropsychiatric Disease and Treatment
researchProduct

Development Of a Disease Specific Quality Of Life Questionnaire For Patients With Aplastic Anemia and/Or Paroxysmal Nocturnal Hemoglobinuria (QLQ-AA/…

2013

Abstract Introduction Acquired Aplastic Anemia (AA) and Paroxysmal Nocturnal Hemoglobinuria (PNH) are ultra-rare diseases with a yearly incidence 2 to 4 per million (AA) and of 1.3 to 2 per million (PNH. While much is known about pathophysiology and treatment of these interrelated diseases, less is known about patients (pts.) psycho-social issues. Quality of life (QoL) evaluation tools used in all studies for AA and PNH are rather unspecific and were initially designed for cancer patients (e.g. the European Organization of Research and Treatment (EORTC) QLQ-C30). Given the complexity of AA and PNH, the variation in symptoms and different treatment approaches (immunosuppression, bone marrow …

Pediatricsmedicine.medical_specialtybusiness.industryIncidence (epidemiology)ImmunologyCell BiologyHematologymedicine.diseaseBiochemistryFocus grouphumanitiesQuality of lifeHealth careParoxysmal nocturnal hemoglobinuriaMedicineAplastic anemiabusinessPsychosocialDisease burdenBlood
researchProduct

Descriptive Evaluation of Age-Related Differences in Clinical Manifestation and Treatment of Von Willebrand's Disease in an Open-Label, Prospective, …

2012

Abstract Abstract 4630 Efficacy, tolerability and dosing of a VWF/FVIII concentrate may differ in paediatric, adults, and elderly patients. It is therefore reasonable to collect and evaluate clinical data of patients from different age groups and to look into differences in treatment and reason for treatment with VWF/FVIII concentrate. A cohort of 120 patients suffering from all types of von Willebrand's disease (VWD) from an on-going German post-marketing surveillance study was analysed for age-related differences in treatment with a high-purity, double virus inactivated VWF/FVIII concentrate (wilate®). Results: Thirteen children up to 12 years of age and 14 patients being 65 or older were…

Pediatricsmedicine.medical_specialtybusiness.operationDosebusiness.industryReason for TreatmentImmunologyCell BiologyHematologyDiseaseOctapharmaBiochemistryVon willebrandTolerabilityCohortmedicineDosingbusinessBlood
researchProduct

Final Evaluation Of a Prospective, Non-Interventional Study On Efficacy and Tolerability Of a New Generation VWF/FVIII Concentrate In The Treatment O…

2013

Background With marketing authorization in 2005, a non-interventional study (SET = Surveillance of Efficacy and Tolerability) with a double virus inactivated VWF/FVIII concentrate (Wilate®) was initiated in Germany. In 2012, the inclusion of patient documentation was terminated for final evaluation of the study data, representing the treatment of 170 patients suffering from von Willebrand’s disease (VWD). Aim The presented study was performed to assess the haemostatic efficacy and safety of a newly introduced VWF/FVIII product in the treatment of all types of VWD patients in every day clinical setting and to validate the results from pivotal clinical trials. Methods Patients of any age suf…

Pediatricsmedicine.medical_specialtybusiness.operationbusiness.industryImmunologyCell BiologyHematologyDiseasemedicine.diseaseOctapharmaBiochemistryClinical trialRegimenDisease severityTolerabilityNon interventionalVon Willebrand diseasemedicinebusinessBlood
researchProduct